In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Industry: Global GCPs, Final Rule Should Precede FDA Foreign Study Guidance

This article was originally published in The Gray Sheet

Executive Summary

Medical device makers are concerned about a lack of globally harmonized standards for good clinical practices, which they say could cause problems for a guidance FDA has drafted on studies conducted outside the U.S.

You may also be interested in...

21st Century Cures: Select Device Provisions

A run-down of key provisions impacting the medical device and diagnostics industry in the 21st Century Cures legislation, which passed the House by a 344-77 vote July 10.

Collecting Foreign Data? Come Talk To Us, FDA Says

FDA has been accepting data from patients outside of the U.S. to support device approvals for years, but the sponsor should check with the agency in advance to ensure the foreign data meets the needs of the U.S. regulatory system, according to a new draft guidance. The guidance details the factors that could stand in the way of FDA accepting foreign data and provides examples of what could be done about it.

Industry Wants Harmonized Good Clinical Practices Before FDA Finalizes OUS Studies Rule

AdvaMed says FDA’s proposed rule on requiring foreign studies to follow good clinical practice guidelines should not be finalized until an international medical device and IVD clinical guideline has been established and adopted.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts